Research consistently shows that the benefits of vitamin K2 extend beyond normal blood coagulation: it supports bone strength and cardiovascular health without causing excessive clotting or increasing blood thickness. For product developers and brands in nutraceutical, pharmaceutical, and functional food and beverage markets, that distinction matters when evaluating ingredients that can support healthy aging while addressing consumer concerns about safety.
We can confidently debunk the widespread myth that Vitamin K2 may elevate coagulation levels, while also outlining its clinically relevant role in bone and vascular health, key safety considerations, and what to watch for around supplement validation and potential drug interactions.
Do you know the vitamin k family?
Vitamin K is vital for maintaining proper blood coagulation, a natural and healthy process that stops excessive bleeding. This raises a common question: Does Vitamin K increase blood thickness or elevate the risk of thrombosis?
Vitamin K, historically viewed as a single nutrient, is a group of fat-soluble vitamins essential for human health. The two key forms are Vitamin K1, which comes mainly from green leafy vegetables and other plant sources, and Vitamin K2, which is obtained from dietary sources such as fermented soybeans, other fermented foods, and animal products.
Vitamin K1 is essential for blood clotting and wound healing, and it is quickly filtered from the bloodstream after performing that role. In contrast, Vitamin K2 is a fat-soluble nutrient that plays a critical role in calcium distribution in the body. K2 activates osteocalcin, the vitamin K-dependent protein (VKDP) involved in healthy bones, bone mineralization, and bone strength, and the VKDP Matrix Gla Protein (MGP) that protects cardiovascular health. Unlike K1, Vitamin K2 remains in the body longer, making it more available to tissues and potentially offering important benefits for bone health and heart health.
Vitamin k2 and blood coagulation
Prothrombin, a protein activated by Vitamin K, is central to the blood coagulation process. It influences clotting when necessary but does not determine blood thickness. Vitamin K ensures that clotting factors function optimally, stopping harmful bleeding. Beyond coagulation, Vitamin K2 activates proteins that help bind calcium appropriately to bones instead of allowing it to accumulate in blood vessels or other soft tissues. A deficiency in Vitamin K, however, leads to impaired coagulation, resulting in prolonged bleeding. Low vitamin K status is also associated with a higher risk of bone fractures because K2 helps activate osteocalcin to bind calcium in bones.
While Vitamin K2 activates clotting proteins like K1, it does not increase the risk of thrombosis in healthy individuals. The liver primarily uses Vitamin K1 for coagulation processes, leaving K2 available for other functions, such as supporting bone metabolism and working with vitamin D to help maintain healthy bone strength.
Coumarin: The only concern with vitamin k2 and vitamin k antagonists
Patients on Vitamin K antagonists like warfarin should consult a healthcare provider before supplementing with Vitamin K2. Warfarin and similar drugs inhibit Vitamin K, which can impair activation of matrix Gla protein (MGP) that helps inhibit vascular calcification. When K2 status is low, inactive MGP rises, calcium is more likely to deposit in arteries and blood vessels, and cardiovascular risk may increase. Fortunately, new anticoagulant drugs, such as direct oral anticoagulants (DOACs) and anti-platelet medications like aspirin, do not interfere with Vitamin K2, allowing for safe supplementation, which matters for heart health in people taking Vitamin K antagonists.
MenaQ7®: Proven safe and effective
Clinical research on MenaQ7® Vitamin K2 has demonstrated no increase in blood-clotting risk or coagulation levels. Studies across children, adults, healthy subjects, and people with chronic kidney disease confirm stable thrombin and coagulation parameters, reinforcing the safety and efficacy of Vitamin K2 for supporting bone and cardiovascular health, and even high doses have not shown increased coagulation risk in this research.
With advancements in antithrombotic medications, MenaQ7® Vitamin K2 can be safely integrated into routines to promote healthy aging and development while maintaining robust cardiovascular and bone health. In study participants with chronic kidney disease, impaired vitamin K status is linked to a higher risk of vascular calcification and worse cardiovascular outcomes, supporting the potential benefits of Vitamin K supplementation for cardiovascular health in these settings.
Do you want to know more? Please, do not hesitate to contact our experts.
Deep dive into k2 and bone health
Significant research shows Vitamin K2 from natural fermentation—especially its key long chain isomer MK-7—to be essential for bone- and cardiovascular-health support. Natto, made from fermented soybeans, is one of the richest food sources, providing significant amounts at 998 μg per 100 g. In Western diets, dietary intake of K2-rich foods can be relatively low, so it is recommended to consider dietary supplements when increasing through diet alone is not possible.
